Stockreport

AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal

AIM ImmunoTech Inc.  (AIM) 
PDF OCALA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (“AIM” or the “Company”) (NYSE American: AIM), an immuno-pharma company focused on the research and [Read more]